Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation is a research paper published in Blood (2022). On theSindex it has a DataRank of 0. It has been cited 55 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Research Council
Grant: 681012
Swiss National Science Foundation
Grant: 183478
NHLBI NIH HHS
Grant: R01 HL056067
Swiss National Science Foundation
Grant: 310030
Swiss National Science Foundation
Grant: 188450
NIAID NIH HHS
Grant: R37 AI034495
MeSH Terms